Complete pathological remission after neoadjuvant ensartinib in patients with locally advanced lung adenocarcinoma and with CTLC-ALK and ALK-DHX8 rearrangements.
作者信息
Wang Cheng, Hu Qikang, Sun Yi, Yu Fenglei, Peng Muyun
机构信息
Department of Thoracic Surgery, The Second Xiangya Hospital of Central South University, Changsha, China.
Department of Thoracic Surgery, The Second Xiangya Hospital of Central South University, Changsha, China; Hunan Key Laboratory of Early Diagnosis and Precise Treatment of Lung Cancer, The Second Xiangya Hospital of Central South University, Changsha, China; Early-Stage Lung Cancer Center, The Second Xiangya Hospital of Central South University, Changsha, China.
出版信息
Eur J Cancer. 2022 Jul;169:131-134. doi: 10.1016/j.ejca.2022.04.012. Epub 2022 May 11.
PMID:35567918
Abstract
摘要
Zotero 插件